1. Home
  2. LGND vs BATRA Comparison

LGND vs BATRA Comparison

Compare LGND & BATRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGND
  • BATRA
  • Stock Information
  • Founded
  • LGND 1987
  • BATRA 1991
  • Country
  • LGND United States
  • BATRA United States
  • Employees
  • LGND 68
  • BATRA N/A
  • Industry
  • LGND Biotechnology: Pharmaceutical Preparations
  • BATRA Broadcasting
  • Sector
  • LGND Health Care
  • BATRA Industrials
  • Exchange
  • LGND Nasdaq
  • BATRA Nasdaq
  • Market Cap
  • LGND 3.2B
  • BATRA 2.9B
  • IPO Year
  • LGND 1992
  • BATRA N/A
  • Fundamental
  • Price
  • LGND $191.31
  • BATRA $43.14
  • Analyst Decision
  • LGND Strong Buy
  • BATRA Strong Buy
  • Analyst Count
  • LGND 8
  • BATRA 3
  • Target Price
  • LGND $144.71
  • BATRA $58.00
  • AVG Volume (30 Days)
  • LGND 139.7K
  • BATRA 51.6K
  • Earning Date
  • LGND 08-05-2025
  • BATRA 11-05-2025
  • Dividend Yield
  • LGND N/A
  • BATRA N/A
  • EPS Growth
  • LGND N/A
  • BATRA N/A
  • EPS
  • LGND N/A
  • BATRA N/A
  • Revenue
  • LGND $181,488,000.00
  • BATRA $702,443,000.00
  • Revenue This Year
  • LGND $18.41
  • BATRA $14.16
  • Revenue Next Year
  • LGND $18.87
  • BATRA $3.97
  • P/E Ratio
  • LGND N/A
  • BATRA N/A
  • Revenue Growth
  • LGND 53.40
  • BATRA 6.51
  • 52 Week Low
  • LGND $81.74
  • BATRA $38.67
  • 52 Week High
  • LGND $129.90
  • BATRA $50.50
  • Technical
  • Relative Strength Index (RSI)
  • LGND 66.71
  • BATRA 42.01
  • Support Level
  • LGND $182.87
  • BATRA $42.00
  • Resistance Level
  • LGND $194.44
  • BATRA $43.35
  • Average True Range (ATR)
  • LGND 5.79
  • BATRA 0.74
  • MACD
  • LGND -0.38
  • BATRA 0.08
  • Stochastic Oscillator
  • LGND 81.23
  • BATRA 56.90

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

About BATRA Atlanta Braves Holdings Inc. Series A

Atlanta Braves Holdings Inc is a holding company. It operates through its wholly-owned subsidiary, which is the owner and operator of the Atlanta Braves Major League Baseball Club and the mixed-use real estate development, The Battery Atlanta, and is the operator of the Atlanta Braves Major League Baseball Club's stadium, Truist Park. The company predominantly derives revenue related to the Braves baseball franchise and Truist Park from ticket sales, concessions, local broadcasting rights, advertising sponsorships, suites and premium seat fees, retail and licensing revenue, shared MLB revenue streams, including national broadcasting rights and licensing, and other sources. The company's reportable segments include: Baseball which generates key revenue, and Mixed-Use Development.

Share on Social Networks: